fda novavax - Search News

News

New COVID vaccine approved by US FDA

FDA approves Moderna's next-generation COVID vaccine for adults 65 and older

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company said Saturday, the first approval under new regulations.

FDA approves a next-generation Covid vaccine from Moderna, with restrictions

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing Covid shot does not currently face.

FDA Approves Novavax COVID Vaccine With Restricted Use

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from COVID can also get the shot.

13d

FDA Gives Full OK to Novavax COVID Shot for High-Risk Groups

Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...

11d

Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

1don MSN

US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

New FDA Covid-19 Policy Supports Vaccines for High-Risk Groups, More Clinical Trials for Others

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results